Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review.
Apoptotic bodies
Biomarkers
Exosomes
Extracellular vesicles
Mesothelioma
Microvesicles
Oncosomes
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
03
02
2020
revised:
28
03
2020
accepted:
30
03
2020
pubmed:
25
4
2020
medline:
17
6
2020
entrez:
25
4
2020
Statut:
ppublish
Résumé
Extracellular vesicles (EV) are secreted by all cells, including cancer cells, as a mode of intercellular transport and communication. The main types of EV known to date include exosomes, microvesicles and apoptotic bodies, as well as oncosomes and large oncosomes, which are specific to cancer cells. These different EV populations carry specific cargo from one cell to another to stimulate a specific response. They can be found in all body fluids and can be detected in liquid biopsies. EV released from mesothelioma cells can reveal important information about the molecules and signalling pathways involved in the development and progression of the tumour. The presence of tumour-derived EV in circulating body fluids makes them potential novel biomarkers for early diagnosis, prognostication and surveillance of cancer. In this review, we explore the characteristics and functional roles of EV reported in the literature, with a focus on their role in malignant pleural mesothelioma.
Identifiants
pubmed: 32330840
pii: S1040-8428(20)30087-1
doi: 10.1016/j.critrevonc.2020.102949
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102949Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no conflicts of interest relevant to this manuscript.